EMA – EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins held on 5 March 2025: publication of the workshop’s report
Immunoglobulins were first used as replacement therapy in patients with humoral immunodeficiency and are now used for both primary immunodeficiencies (PID) and several secondary immunodeficiencies. They are also used for immunomodulatory indications in patients with...





